Name
Capella university
NURS-FPX 9100: Virtual Check-in 2
Prof. Name
October, 2024
Summary of the key points of the Virtual Check-In
The second virtual check-in allowed reflection on key updates made on the Medication Reconciliation Process Enhancement (MRPE) project. A broader discussion revolved around the improvement done to Part I of the project charter: clarifying objectives, which hereby defined the scope of the project. There was one significant update regarding the inclusion of a workflow analysis tool in the assessment of the current process of medication reconciliation (Baughman et al., 2021). This tool will help in outlining which areas are much affected by inefficiency and gaps, hence being focused on improvements. Together with the input and approval of the professor reviewing, this tool was very crucial in determining the direction of the project.
Discussing the outcome of the progress made in Part I, we covered the status of the charter where I explained methods for measuring outcomes and the roles and responsibilities of the project team. We discussed strategies for making sure that the project’s timeline was feasible by ensuring that enough resources were allocated to achieve our objectives. Some concerns about the final draft submission are that, for all sections to be cohesive in bringing out the topic, encouraging words from my preceptor and professor have minimized the feeling of that. The check-in did give me much insight into what is going on, and it reassured me that the project is headed in the right direction, with clear steps laid out forward for completion.
Reflection on the Progress
I have identified all the relevant stakeholders such as the physicians, pharmacists, nursing staff, and a team leader who has experience with leadership (Maritta Välimäki et al., 2024). Preparation of communication plan: coordination between the executive sponsor, stakeholders, and the team leader along with the proper methods of timely and clear communication. I also had to detail the procedures taken throughout the project related to data collecting and analysis. This includes establishing secure protocols to organize, store, and safeguard the data to ensure its integrity and confidentiality.
Coming to my final submission regarding the Project Charter for MRPE: quite a few questions arise in my mind.
- How do I engage external stakeholders such as your pharmacy vendors and health systems in this project toward winning them over?
- Have I identified all the possible risks and challenges that will come my way during the implementation of my improvements to medication reconciliation?
- Does my Project Charter indicate a very detailed plan for what data is going to be collected, how it will be managed, and what analysis I will do of medication reconciliation outcomes?
- Do I clearly state the expected results and benefits achieved from the MRPE project towards patient safety and care transition?
Regarding promoting a collaborative and shared responsibility culture, I will adopt approaches that promote mutual respect and shared values among team members. It is through such mutual respect and shared values that the desired outcomes toward better medication reconciliation processes and patient safety will be achieved.
Reflection on Areas of Uncertainties
Some of the vague areas of the project charter in parts II and III of the MRPE include gaining support from external stakeholders such as the networks of pharmacies and health systems that ensure the successful implementation of the project (Michel et al., 2021). External stakeholders may criticize the following terms: the fitness of the project, the need for the project, resource allocation, and workflow integration. This can be resolved by novel approaches to communication that would encourage the cooperation of project team members with stakeholders. Such transparent communication about which goals the project will achieve and the various benefits it will bring about is going to bridge a resistance gap. Furthermore, constant collaboration will eventually ensure that care and transition to safety are valued patients’ concerns. This fits the best practices of improvement work in healthcare and emphasizes communication as part of the steps to gain stakeholders’ support, therefore leading to successful outcomes.
Early stakeholder involvement will be ensured during the collection of feedback and validation of concerns before full implementation to further minimize uncertainties. This will help in ownership and engagement, consequently reducing the resistance level. Informing the stakeholders with evidence of how the standardized medication reconciliation checklist can enhance patient safety through reduced medication error is crucial (Chiewchantanakit et al., 2020). Updating this value to the stakeholders constantly through regular project milestones becomes a way of reinforcing the value of the initiative. Open dialogue also ensures that challenges or adjustments during the implementation phase are shared and thus addressed together to increase the chances of longer-term success.
NURS FPX 9100 Assessment 5 Conclusion
Considering this, the MRPE project would greatly influence patients’ safety by minimizing medication errors at the care transition points. Strong collaboration between different stakeholders, clear communication, and strategic and planned use of data collection and analysis will lead to an accurate and comprehensive medication list (Nilsen et al., 2020). In that regard, by addressing the most probable problems that may arise early in the project and by promoting teamwork values, the project is best set up to accomplish its objectives and deliver measurable improvements in patient outcomes, which will enhance the quality of care.
NURS FPX 9100 Assessment 5 References
Baughman, A. W., Triantafylidis, L. K., O’Neil, N., Norstrom, J., Okpara, K., Ruopp, M. D., Linsky, A., Schnipper, J., Mixon, A. S., & Simon, S. R. (2021). Improving medication reconciliation with comprehensive evaluation at a Veterans Affairs skilled nursing facility. The Joint Commission Journal on Quality and Patient Safety, 47(10), 646–653. https://www.sciencedirect.com/science/article/pii/S1553725021001537?via%3Dihub
Chiewchantanakit, D., Meakchai, A., Pituchaturont, N., Dilokthornsakul, P., & Dhippayom, T. (2020). The effectiveness of medication reconciliation to prevent medication error: A systematic review and meta-analysis. Research in Social and Administrative Pharmacy, 16(7). https://www.sciencedirect.com/science/article/abs/pii/S1551741119301706?via%3Dihub
Maritta Välimäki, Hu, S., Tella Lantta, Hipp, K., Jaakko Varpula, Chen, J., Liu, G., Tang, Y., Chen, W., & Li, X. (2024). The impact of evidence-based nursing leadership in healthcare settings: a mixed methods systematic review. BMC Nursing, 23(1). https://bmcnurs.biomedcentral.com/articles/10.1186/s12912-024-02096-4
Michel, D. E., Tonna, A. P., Dartsch, D. C., & Weidmann, A. E. (2021). Experiences of key stakeholders with the implementation of medication reviews in community pharmacies: A systematic review using the consolidated framework for implementation research (CFIR). Research in Social and Administrative Pharmacy. https://www.sciencedirect.com/science/article/pii/S1551741121002758?via%3Dihub
Nilsen, E. R., Stendal, K., & Gullslett, M. K. (2020). Implementation of eHealth technology in community health care: the complexity of stakeholder involvement. BMC Health Services Research, 20(1). https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-020-05287-2
